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Lisa LongatoAbstract
The global diffusion of the so-called Western diet, which is enriched in fat and carbohydrates, such as fructose, has
been proposed to be an underlying cause of the increased prevalence of metabolic conditions, including non-
alcoholic fatty liver disease (NAFLD). This Smart Card summarizes the main metabolic and hepatic histological
features of rodent models fed with diets combining high fat and fructose.
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Western dietIntroduction
Non-alcoholic fatty liver disease (NAFLD), a condition
regarded as the hepatic manifestation of the metabolic
syndrome, currently represents the most common cause
of chronic liver disease [1]. The condition ranges from
simple hepatic fat accumulation (steatosis) to non-
alcoholic steatohepatitis, where fat is accompanied by
hepatocyte injury, and necroinflammation. This con-
dition poses an increased risk of cirrhosis and hepa-
tocellular carcinoma [1]. The dramatic increase in
prevalence of obesity, metabolic syndrome, and NAFLD
has been linked to the global diffusion of the Western
diet, characterized by excess caloric intake due to in-
creased consumption of processed food and beverages,
coupled with a more sedentary lifestyle [2,3]. This has
led to a significant increase in sucrose and high-fructose
corn syrup consumption, both of which contain similar
amounts of glucose and fructose [4]. In the USA, for ex-
ample, fructose consumption has more than doubled in
the last three decades [3]. Excessive fructose consump-
tion has been linked to an increased prevalence of meta-Correspondence: l.longato@ucl.ac.uk
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reproduction in any medium, provided the orbolic diseases and growing evidence suggests that it may
also contribute to the development and severity of
NAFLD by exacerbating fat deposition, inflammation,
and, possibly fibrosis [5]. Mechanistically, fructose may
contribute to NAFLD by promoting de-novo lipogenesis,
insulin resistance, oxidative stress, bacterial overgrowth,
and inflammation [3-7]. The mechanisms responsible
for transition to non-alcoholic steatohepatitis are still
not completely understood, in part because of the
scarcity of animal models that can fully replicate both
the histological and metabolic features of human non-
alcoholic steatohepatitis [8]. As fructose is likely to act
as a dietary ‘second hit’ [5], effort has recently been put
into developing novel experimental models to recapitu-
late the Western diet by combining high-fat or high-
energy diets and fructose. The aim of this Smart Card is
to provide a synthetic and exhaustive source for rapid
consultation of the currently proposed rodent models of
diets combining high fat and fructose, summarizing the
metabolic and hepatic consequences of such combina-
tions (Table 1).This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Metabolic and hepatic features of rodent models fed with diets combining high fat and fructose
Name of model,
species, or strain




Standard chow (13.6% kcal from fat
(soybean oil (15% saturated fatty
acids, 23% monounsaturated fatty
acids, 61% polyunsaturated fatty
acids)) + gel-water;







C57BL/6 J mouse Alios diet: 45% kcal from fat (30%
from partially hydrogenated
vegetable oil (28% saturated fatty
acids, 57% monounsaturated fatty
acids, 13% polyunsaturated fatty
acids) + high-fructose corn syrup
equivalent (55% fructose, 45%
glucose by weight) (42 g/l as gel-
water)
↑ liver triglycerides; macrosteatosis (zones 1
and 2), microsteatosis
(zone 3);↑ insulin, ↑ leptin;














High-fat diet (58% kcal from fat); ↑ glucose/insulin (fasting); steatosis (micro, macro);
C57BL/6 J mouse High-fat diet + water with high-
fructose corn syrup equivalent
(55% fructose and 45% sucrose
by weight (42 g/l))
↑ HOMA-IR; lobular inflammation,
↑ apoptosis;
↑ liver triglycerides ballooning: not assessed
or not reported;
↑ fibrosis
Fast-food mouse Standard chow (13% kcal from fat
(1% saturated fatty acids) + high-
fructose corn syrup in water (42 g/l));
25 ↑ body weight, ↑ liver
weight;
↑ aspartate [8]
C57BL/6 J mouse High-fat diet (60% kcal from fat (1%
saturated fatty acids) + high-fructose




Fast-food diet (40% kcal from fat
(12% saturated fatty acids) +2%
cholesterol + high-fructose corn
syrup in water (42 g/l))
↑ HOMA-IR; steatosis: panacinar;
↓ adiponectin; (++ macro, + micro);






Control diet (4.8% fat); 8 ↑ body weight, = liver
weight;
Liver function tests: not
assessed or not reported;
[11]






↑ HOMA-IR, ↑ GTT-AUC; (↑ Oil Red O);
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Table 1 Metabolic and hepatic features of rodent models fed with diets combining high fat and fructose (Continued)
High-fat diet +
sucrose
Control group (control); 12 ↑ body weight; Liver function tests: not
assessed or not reported;
[12]






Control diet; 8 ↑ body weight, ↑ liver
weight;
Liver function tests: not
assessed or not reported;
[13]
C57BL6/J mouse High-fat diet (72% fat (corn oil/
lard); 28% protein, <1%
carbohydrates) + 21% fructose in
water









Standard chow (5% kcal from fat,
18% proteins, 77% carbohydrates)





Standard chow + fructose in water
(30% w/v);
glucose =, ↑ insulin; ballooning + mild
steatosis;










Standard chow (24% protein, 11%
fat, 65% carbohydrates (% by
weight));







Wistar rats High-fat diet [26% fat, 17%
protein, 4% cholesterol, 53%
carbohydrates) + 10% (w/v)
fructose in water
↑ liver triglycerides, ↑
HOMA-IR;
↑ Oil Red O;
↑ insulin, = glucose
(fasting);
fibrosis: not assessed or
not reported
↑ leptin, ↓ adiponectin
High-fat diet +
fructose (water)
Normal chow (4% fat); 48 ↑ body weight, ↑ liver
weight;
Liver function tests,





High-fat diet (60% kcal from fat) +
10% fructose in water








Low-fat diet: 10% kcal from fat; 10 ↑ Body weight, ↑ liver
weight;





Western diet: high-fat diet (45%
kcal from fat (soybean oil, lard)) +
high-fructose corn syrup-55 (55%
fructose, 45% glucose diluted
with water to 12.5%)
↑ GTT-AUC/↑ leptin; ↑ liver fat score, ↑ NAFLD
activity score;
= triglycerides (plasma); = lobular inflammation,
= ballooning;
↓ cholesterol (plasma) fibrosis: no
High-fat diet +
fructose (water)







Wistar rats High-fat, fructose diet (52%
carbohydrate, 24% fat, 25%
fructose in drinking water)
↑ basal glucose; ↑ fat vacuoles;
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Control group (cornstarch diet); 5 = body weight; = alanine
aminotransferase;
[20]
High fructose (70% by weight); = plasma triglycerides; some macrosteatosis;
Wistar rats High sucrose (70%); = glucose; inflammation: =lobular, =
portal;
High fat (15%); = liver triglycerides fibrosis: no change












Wistar rats High-carbohydrate (fructose/
sucrose), high-fat diet
↑ visceral adiposity; = liver triglycerides, lipid
deposition;
↑ % body fat inflammation;













Wistar rats High-carbohydrate, high-fat diet
(including condensed milk
(39.5%), beef tallow (20%), and
fructose (17.5%)) + 25% fructose
in water
↑ glucose, = insulin
(fasting);
↑ macrosteatosis;




aAll indicated changes refer to the experimental group in bold compared with either a control diet or other listed groups.
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GTT-AUC: Glucose tolerance test: area under the curve; HOMA-
IR: Homeostasis model of assessment - insulin resistance; NAFLD:
Non-alcoholic fatty liver disease; w/v: Weight by volume.
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